POCARED Diagnostics

About:

POCARED Diagnostics is revolutionizing infections disease practice with culture-free microbiology.

Website: http://www.pocared.com/

Top Investors: European Investment Bank, Elron Ventures

Description:

POCARED DiagnosticsTM is an in-vitro diagnostics company developing a next generation microbiology platform. POCAREDTM is revolutionizing infectious disease diagnosis with CULTURE-FREE MicrobiologyTM POCARED’sTM P-1000TM; a platform that is fully automated, reagent free, real time, and easy to operate. POCARED'TM saves several critical days in result reporting by providing multi-source detection, quantification and species identification results for bacteria and yeast in few minutes, directly from the specimen.

Total Funding Amount:

$78.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Rehovot, HaMerkaz, Israel

Founded Date:

2004-01-01

Contact Email:

info(AT)pocared.com

Founders:

Gal Ingber, Jonathan Gurfinkel

Number of Employees:

11-50

Last Funding Date:

2022-05-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai